- New York Abilify Lawsuit Lawyer
- New York Actos Lawsuit Lawyer
- New York Benicar Lawsuit Lawyer
- New York Invokana Lawsuit Lawyer
- New York Januvia Lawsuit Lawyer
- New York Onglyza and Kombiglyze XR Lawsuit Lawyer
- New York Opioids Lawsuit Lawyer
- New York Pradaxa Lawsuit Lawyer
- New York Risperdal Lawsuit Lawyer
- New York Talcum Powder Lawsuit Lawyer
- New York Taxotere Lawsuit Lawyer
- New York Victoza Lawsuit Lawyer
- New York Vioxx Lawsuit Lawyer
- New York Xarelto Lawsuit Lawyer
- New York Zostavax Lawsuit Lawyer
- MAIN Defective Drugs & Devices
New York Risperdal Lawsuit Lawyer
Risperdal is a drug initially developed to treat schizophrenia which has also been prescribed for symptoms of autism and bipolar disorder. It has been known to lead to serious health issues and sometimes even death to the user.
Risperdal side effects:
- Children have a gynecomastia risk five times higher than the label indicated
- High psychological burden of gynecomastia diagnosis
- Premature puberty in females
- Hyperprolactinemia in females/males causing lactation in those not breastfeeding or pregnant
- Increased prolactin levels
- Loss of libido
- Weight gain
- Heart attacks
- Fertility issues
- Insulin resistance possibly leading to type 2 diabetes
- Tardive dyskinesia
If so, we understand how frightening it is to be taking a drug you thought would help you cope with your day to day life, only to discover that it could not only cause you great harm but result in your death. Sobo & Sobo L.L.P. has won personal injury settlements for thousands of New York victims and we are here to help. Talk to us, we want to hear your story.
A History Of Risperdal And The FDA
Risperdal is risperidone, a psychotropic agent in the chemical class of benzisoxazole derivatives with ranges in strength from 0.25 mg to 4 mg.
In 1994 the FDA first approved this drug for treating schizophrenia. Because of a patent set to expire in 2003, the manufacturer Johnson & Johnson/Janssen had no other drug companies competing with them in the marketplace.
In 1995, Johnson & Johnson set up a project to encourage doctors to prescribe Risperdal for off-label use, specifically targeting it to seniors and kids. They petitioned the FDA to approve the drug for use by seniors but were denied. In 1996 they petitioned the FDA again, this time to allow children to use the drug. They were refused for a second time.
In 1999, the FDA once again denied J&J’s request to expand approval to the elderly, stating that the drug maker had “failed to fully explore and explain what appeared to be an excess number of deaths” among elderly Risperdal users.
While lobbying the FDA to allow them to expand the use of their drug for kids and seniors, Johnson & Johnson promoted the drug for children, offering kickbacks to medical doctors, creating back to school marketing campaigns, where they handed out candy and toys with Risperdal printed on them.
From 1999 to 2005, J&J were warned multiple times about promoting Risperdal for use by young people. Despite those warnings, J&J also promoted it for use in patients with mental disabilities. In 2006, the FDA did approve Risperdal for use by adolescents and children, particularly those suffering with autism. It also eventually approved Risperdal for use with the elderly.
Lawsuits And An Investigation By The Justice Department
Over 14,000 and counting lawsuits have been filed in the United States against drug maker Johnson & Johnson/Janssen Pharmaceuticals for the dangerous and deadly side effects of Risperdal (risperidone).
Lawsuits filed against J&J/Janssen alleged the company did not adequately warn consumers of the risk of young male patients developing female breast tissue. Despite doctors asking the drug maker to update Risperdal’s label to include this warning, it was not done. It was further alleged that J&J knew of the risks but altered data and repressed key evidence to continue their push to get FDA approval to market the drug to children.
In 2012, the Justice Department and J&J settled the investigation into its marketing and promotion of Risperdal. J&J ultimately paid out a fine of $2.2 billion, the largest fine in U.S. pharmaceutical history. At issue was J&J’s promotion and marketing of Risperdal (and other drugs) for unapproved, off-label uses such as treating: agitation; confusion; anxiety; hostility and depression.
You Have A Right To Be Compensated
If you or a loved one has been injured by Risperdal, speak to an experienced attorney. You may seek compensation for several items, including, but not limited to:
- Loss of income
- Past, present and future medical expenses
- Pain and suffering – such as humiliation from a side effect such as gynecomastia
- Funeral and burial expenses
- Punitive damages
Have you or a loved one been taking Risperdal and experienced severe side effects? Contact an attorney to learn more about your legal rights and begin the process of filing a lawsuit to obtain compensation.
Help For Your Defective Drug Case
The attorneys at Sobo & Sobo are personal injury law leaders who are dedicated to using their years of experience to help. Take the time to learn about your legal rights, call Sobo & Sobo at 855-468-7626 as soon as possible. During your initial consultation, we listen to your story and help you make informed decisions about how to proceed.
We understand it is a difficult time and want to be there on every step of your journey through the defective drug litigation process. Our prompt action, in partnership with you, could make a difference in the outcome of your case. We would be honored to hear your story and look forward to taking the next step toward Winning Together.